Axiom Clinical Research | Enrolling Trials

Enrolling Studies

Axiom is currently enrolling patients in Multiple Sclerosis, Alzheimer’s Disease, Essential Tremor and Migraine studies.

If you or a loved one would be interested in participating in a study for any of the listed fields, or if you would like more information on our studies, please contact us at or

813-353-9613.

CURRENTLY ENROLLING STUDIES

Alzheimer's Disease

Learn More

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy and Safety of JNJ-63733657, an Anti-Tau Monoclocal Antibody, in Participants with Early Alzheimer's Disease

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease

Multiple Sclerosis

Learn More

Multiple enrolling studies available, click the link to find out which study may be right for you.

Alzheimer's Disease with Agitation

Learn More

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-786 (deudextromethorphan hydrobromide/quinidine sulfate) for the Treatment of Agitation in Patients with Dementia of the Alzheimer’s Type

Migraine

Learn More

Would you like to receive a copy of our quarterly newsletter? Click here to sign up to receive updates on currently enrolling trials, upcoming events, noteworthy news and more.

Our office is currently open for patient visits, but is closed to on-site monitoring visits. If you are experiencing a cough, fever, or any other signs of illness, please call the office at 813-353-9613 before your appointment to reschedule.

All patients are subject to screening before entering the office. Please call the office with any questions or concerns, and arrive to scheduled appointments with a mask or face covering.

Enrolling Studies

CURRENTLY ENROLLING STUDIES